Popular nollywood actress, Opeyemi Aiyeola, is currently lying ack at the hospital where she is receiving treatment and medications. The renowned actress made this known on Tuesday on her Instagram page. Opeyemi, who shared a video of herself advised her fans to always read the prescription on drugs before taking them. She said she purchased a malaria drug over the counter and she took it after drinking 'Gaari' on her way home.
Ope said she failed to read the instructions written on the leaflet of the said drug as one of the side effects was drowsiness and dizziness. The actress said she passed out twice at work when she started feeling dizzy. The actress said she failed to go for a test to confirm whether she had malaria before taken the drug. She explained that it was after she passed out at a location that they rushed her down to the hospital, where she is currently receiving treatment.
Fans have prayed for her that God will heal her.
Content created and supplied by: Bonkay (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More